McKesson : OJEMDA FDA Approved for Pediatric Low Grade Glioma : vimarsana.com

CARY, N.C., April 26, 2024 -Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited...

Related Keywords

George Paschal , Specialty Solutions , Drug Administration , Sarah Cannon Research Institute , Us Oncology Network , Business Development For Biologics , Mckesson Provider Solutions , Mckesson Corporation , Mckesson , Us Oncology Research , Day One Biopharmaceuticals , Rare Pediatric Disease Designation , Business Development , Day One , Mckesson Oncology , Sarah Cannon Research , Markets ,